# Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

> **NCT03804255** · — · WITHDRAWN · sponsor: **ECOG-ACRIN Cancer Research Group**

## Conditions studied

- Breast Carcinoma
- Colorectal Carcinoma
- Community Practice
- Lung Carcinoma
- Melanoma
- Solid Neoplasm

## Interventions

- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT03804255
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-08
- **Primary completion:** 2020-05-29
- **Final completion:** 2020-05-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study closed before patients enrolled
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03804255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03804255, "Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03804255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*